Annoucing the arrival of Canixin® L, a new L2 Leptospirosis vaccine for dogs

We are pleased to announce the addition of Canixin® L, a new L2 Leptospirosis vaccine for dogs, to our comprehensive companion animal vaccine range.

Updated 26.03.2026

Technical support

Contact support teams with any question by phone or via our quick form.

Canixin-L

Canixin® L is an inactivated bacterial vaccine suspension specifically formulated to stimulate active immunity in dogs against two critical serogroups of Leptospira interrogans: Canicola and
Icterohaemorrhagiae. Leptospirosis is a bacterial infection that can infect multiple species and is zoonotic, meaning it has the potential to be transmitted to humans.

Licensed to reduce infection, clinical signs, kidney colonisation, renal lesions, and importantly, shedding in the urine, Canixin® L plays a crucial role in minimising the risk of the disease to both the individual and other animals that may come into contact.

The vaccine is licensed for use in dogs from 8 weeks of age, with a second injection administered 3 to 4 weeks later. For the Canicola serogroup, Canixin® L offers a high level of protection, including prevention of mortality.

Clinical signs of leptospirosis can vary widely, ranging from mild, non-specific illness to fatal outcomes. Most commonly, signs manifest as acute kidney injuries and/or liver dysfunction. While historically considered a ‘rural’ disease, current consensus indicates that all dogs are at risk regardless of breed, age, geographic location, or lifestyle, with no specific lifestyle eliminating risk.

Exposure can occur through:

  • Direct contact with wildlife (rodents) or their urine
  • Indirect contact with contaminated soil, puddles, or bedding
  • Social contact with other dogs

“We are pleased to be able to offer Canixin® L, allowing those using Canixin® DHPPi/L to vaccinate with L2 only in the intermediate years.”, said Rain Beckles – Product Manager. “It also provides an excellent opportunity for practices with clients specifically requesting an L2 vaccine.”

For more information on Canixin® L or any other vaccine in the Virbac range, contact your Virbac
Territory Manager or Virbac directly Tel: 01359 243243 Email: enquiries@virbac.co.uk

Keep up to date with Virbac

Get updates on Virbac products, access the latest CPD training modules, and receive resources to support your practice.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Yes, I would like to receive email updates on Virbac products, free CPD modules, and practice support resources. You can unsubscribe at any time via the link in our emails.

Find information and products for your clients

on the Virbac pet owner website

Send resource by email

Send to*
Send me a copy of this email

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Welcome to Virbac Pro

This website is intended for veterinary professionals.

I’m a pet owner
Virbac Pro

Power your practice with Virbac Pro.

Access a full suite of product information, clinic resources, CPD training, technical support and more, all in one place.

Enter your email address to log in or sign up